A detailed history of Catalyst Funds Management Pty LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 10,800 shares of CRL stock, worth $1.52 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
10,800
Holding current value
$1.52 Million
% of portfolio
0.43%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$150.52 - $190.14 $1.63 Million - $2.05 Million
10,800 New
10,800 $1.63 Billion

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.17B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.